Product Information
LEVSIN-SL 0.125 MG TABLET SL is a brand product labeled by Viatris Specialty LLC, priced at $2.7142 per EA under NDC 68220011310. Its NADAC has been published 80 times since Sep 18, 2024.
The High Outlier badge above means this manufacturer's average price in the hyoscyamine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.125 mg/1
Manufacturer
Viatris Specialty LLCNDC
68220011310
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYOSCYAMINE SULFATEApproval Type
Unapproved
On Market Since
12/1/2008
Price Statistics
The NADAC for LEVSIN-SL 0.125 MG TABLET SL has been published 80 times since Sep 18, 2024, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7142 per EA |
|---|---|
| All-time high | $2.7142 (Jun 24, 2026) |
| All-time low | $2.5253 (Oct 23, 2024) |
| 52-week high | $2.7142 |
| 52-week low | $2.6515 |
| Median price | $2.6515 |
| Average price | $2.6344 |
| Largest weekly change | +5.0% (Jan 15, 2025) |
| Weeks tracked | 80 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVSIN-SL 0.125 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for LEVSIN-SL 0.125 MG TABLET SL, manufactured by Viatris Specialty LLC, is $2.7142 per EA (NDC 68220011310), effective Jun 24, 2026.
How has the price of LEVSIN-SL 0.125 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for LEVSIN-SL 0.125 MG TABLET SL has risen 6.0%. It has been tracked across 80 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for LEVSIN-SL 0.125 MG TABLET SL?
Since Sep 18, 2024, the NADAC for LEVSIN-SL 0.125 MG TABLET SL has ranged from a low of $2.5253 (Oct 23, 2024) to a high of $2.7142 (Jun 24, 2026), with a median of $2.6515 per EA.
Are there cheaper alternatives to LEVSIN-SL 0.125 MG TABLET SL?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYOSCYAMINE SULF 0.125 MG TAB, is $0.1697 per EA — about 94% below LEVSIN-SL 0.125 MG TABLET SL.
Who manufactures LEVSIN-SL 0.125 MG TABLET SL?
LEVSIN-SL 0.125 MG TABLET SL (NDC 68220011310) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification